This share is set to skyrocket on SAMR approval. Let's hope it is around the corner.
A2M on the otherhand is at the mercy of a shorting consortium. I hold both but see more upside in BAL and more downside in A2M.
CBEC delays or guidance on implementation will help both companies and the IF sector in general. News should be imminent.
Warning, page-87
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
